Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK-Reference-Cited by-同舟云学术

Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK

Published:2020-02-25 Issue:2 Volume:15 Page:e0229224
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Matthews Ian^ORCID,Duong Mai,Parsons Victoria L.,Nozad Bayad,Qizilbash Nawab,Patel Yash,Guimicheva Boriana

Funder

Merck Sharp and Dohme

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis;RE Hope-Simpson;Proc R Soc Med,1965

2. Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus;TH Weller;N Engl J Med,1983

3. Recommendations for the Management of Herpes Zoster;RH Dworkin;Clin Infect Dis,2007

4. Harding DM. Shingles (Herpes Zoster) | Symptoms, Causes and Treatments: @patient; 2018. https://patient.info/health/shingles-herpes-zoster-leaflet.

5. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom;A Gauthier;Epidemiol Infect,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Incidence of Herpes Zoster Complications: A Systematic Literature Review;Infectious Diseases and Therapy;2024-06-19

2. Herpes zoster vaccine and the risk of stroke: a population-based cohort study using linked data from the Clinical Practice Research Datalink;BMJ Public Health;2024-06

3. Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocol;BMC Infectious Diseases;2024-03-19

4. Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocol;2024-02-20

5. COVID-19 and herpes zoster: a call to action;Frontiers in Public Health;2023-08-10